Nilotinib protects the murine liver from ischemia/reperfusion injury
Authors:
- Shan ZengSZShan Zeng
- Michael J. CavnarMCMichael J. Cavnar
- Eric C. SorensonESEric C. Sorenson
- Zubin M. BamboatZBZubin M. Bamboat
- Jonathan B. GreerJGJonathan B. Greer
- Teresa S. KimTKTeresa S. Kim
- Rachel PopowRPRachel Popow
- Ronald P. DeMatteoRDRonald P. DeMatteo
- 1 October 2012
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 57 (4) , 766-773
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritisArthritis Research & Therapy, 2010
- Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretionJournal of Clinical Investigation, 2010
- Toll-Like Receptor 9 Inhibition Confers Protection From Liver Ischemia–Reperfusion InjuryHepatology, 2010
- Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasomeJournal of Clinical Investigation, 2009
- Tissue-resident Macrophages Protect the Liver From Ischemia Reperfusion Injury via a Heme Oxygenase-1-Dependent MechanismMolecular Therapy, 2009
- C-Jun N-Terminal Kinase 2 Promotes Graft Injury via the Mitochondrial Permeability Transition After Mouse Liver TransplantationAmerican Journal of Transplantation, 2008
- Cellular and Molecular Mechanisms of Liver InjuryGastroenterology, 2008
- The c-jun kinase/stress-activated pathway: Regulation, function and role in human diseaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisJournal of Clinical Investigation, 2006
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003